“Why isn’t this in the newspapers?”
That’s what Dr. John Campbell asked on his YouTube channel yesterday, reviewing several studies of ivermectin as an agent in the fight against COVID-19 — but directly regarding the results of research out of Brazil. It was an impressive large-number study, in which the researchers invited the whole population of Itajaí to participate, with 159,561 included in the analysis: 113,845 regular users of ivermectin and 45,716 non-users.
“Seventy percent reduction in mortality in this study” of those who took a very “tiny dosage of ivermectin every fortnight, acting as a prophylaxis” over those did not. “I mean, this is just huge!”
Dr. Campbell, who has been a voice of calm science during the pandemic, goes on to say that “It’s almost as if information has been deliberately suppressed throughout the pandemic, to be quite honest.” With a wry look, he went on to say “No one’s saying that’s true, of course, but it’s almost like that.”
Droll.
But non-ironically, he insists the evidence is “powerful, present, and overwhelming.”
“Seventy percent,” he marvels, “how do you argue with a number like that? It’s a very, very high number.”
And the decrease in hospitalization was 67 percent.
All in all, the study found less infection, fewer hospitalizations, and an astoundingly lower death rate in the ivermectin group.
Earlier in the video, the doctor considered another study, comparing the cheap anti-parasitic to the far more expensive remdesivir, a Fauci-pushed Gilead Sciences anti-viral, with similar results.
It’s “almost as if” the expert class that spurned ivermectin doesn’t care if people die.
No one’s saying that, but.…
This is Common Sense. I’m Paul Jacob.
The studies:
Kerr L, Cadegiani F A, Baldi F, et al. (January 15, 2022) “Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching.” Cureus 14(1): e21272. doi:10.7759/cureus.21272.
I. Efimenko, S. Nackeeran, S. Jabori, J.A. Gonzalez Zamora, S. Danker, D.Singh, “Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database.” International Journal of Infectious Diseases 116 (2022) S1 – S130.